Cargando…
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPNs) are associated with the fewest number of mutations among known cancers. The mutations propelling these malignancies are phenotypic drivers providing an important implement for diagnosis, treatment response monitoring, and gaining insight into the disease biology....
Autor principal: | Kjær, Lasse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464548/ https://www.ncbi.nlm.nih.gov/pubmed/32731609 http://dx.doi.org/10.3390/cancers12082100 |
Ejemplares similares
-
Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?
por: Fulvio, Giovanni, et al.
Publicado: (2023) -
Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm
por: Fleischman, Angela G.
Publicado: (2015) -
Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
por: Gaulin, Charles, et al.
Publicado: (2022) -
Presence of Polyclonal Hematopoiesis in Females with Ph-negative Myeloproliferative Neoplasms
por: Swierczek, Sabina, et al.
Publicado: (2015) -
Functional Consequences of Mutations in Myeloproliferative Neoplasms
por: Constantinescu, Stefan N., et al.
Publicado: (2021)